Isadora Souza Rodriguez

Isadora Souza Rodriguez

Auto-generated profile, based on publicly available information

Isadora Souza Rodriguez

Pediatric Intensive Care Unit Instituto da Criança e do Adolescente, Hospital das Clínicas da Universidade de São Paulo São Paulo Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Clinics
Verified
Journal Article
Open access
PDF file
MLMichele Luglio
Michele Luglio
UTUenis Tannuri
Uenis Tannuri
WCWerther Brunow de Carvalho
Werther Brunow de Carvalho
KBKarina Lucio de Medeiros Bastos
Karina Lucio de Medeiros Bastos
IRIsadora Souza Rodriguez
Isadora Souza Rodriguez
ADArtur Figueiredo Delgado
Artur Figueiredo Delgado
SARS-CoV-2 shares nearly 80% of its’ genomic sequence with SARS-CoV and MERS-CoV, both viruses known to cause respiratory symptoms and liver impairment. The emergence of pediatric cases of multisystem inflammatory syndrome related to the SARS-CoV-2 infection (PIM-TS) has raised concerns over the issue of hepatic damage and liver enzyme elevation in the critically ill pediatric population with COVID-19. Some retrospective cohorts and case series have shown various degrees of ALT/AST elevation in SARS-CoV-2 infections. A limited number of liver histopathological [...] SARS-CoV-2 shares nearly 80% of its’ genomic sequence with SARS-CoV and MERS-CoV, both viruses known to cause respiratory symptoms and liver impairment. The emergence of pediatric cases of multisystem inflammatory syndrome related to the SARS-CoV-2 infection (PIM-TS) has raised concerns over the issue of hepatic damage and liver enzyme elevation in the critically ill pediatric population with COVID-19. Some retrospective cohorts and case series have shown various degrees of ALT/AST elevation in SARS-CoV-2 infections. A limited number of liver histopathological

1 January 2020 in Clinics
Verified
Journal Article
Open access
PDF file
ACAna Paula de Carvalho Panzeri Carlotti
Ana Paula de Carvalho Panzeri Carlotti
WCWerther Brunow de Carvalho
Werther Brunow de Carvalho
CJCíntia Johnston
Cíntia Johnston
AGAlfredo Elias Gilio
Alfredo Elias Gilio
HMHeloisa Helena de Sousa Marques
Heloisa Helena de Sousa Marques
ADArtur Figueiredo Delgado
Artur Figueiredo Delgado
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), became a pandemic in March 2020, affecting millions of people worldwide. However, COVID-19 in pediatric patients represents 1-5% of all cases, and the risk for developing severe disease and critical illness is much lower in children with COVID-19 than in adults. Multisystem inflammatory syndrome in children (MIS-C), a possible complication of COVID-19, has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease [...] Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), became a pandemic in March 2020, affecting millions of people worldwide. However, COVID-19 in pediatric patients represents 1-5% of all cases, and the risk for developing severe disease and critical illness is much lower in children with COVID-19 than in adults. Multisystem inflammatory syndrome in children (MIS-C), a possible complication of COVID-19, has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease

28 February 2022 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
PZPatrícia Zamberlan
Patrícia Zamberlan
ACAna Paula de Carvalho Panzeri Carlotti
Ana Paula de Carvalho Panzeri Carlotti
KVKarina Helena Canton Viani
Karina Helena Canton Viani
IRIsadora Souza Rodriguez
Isadora Souza Rodriguez
JSJosiane de Carvalho Simas
Josiane de Carvalho Simas
ADArtur Figueiredo Delgado
Artur Figueiredo Delgado

1 April 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
WCWerther Brunow de Carvalho
Werther Brunow de Carvalho
IRIsadora Souza Rodriguez
Isadora Souza Rodriguez
EMEmiliana Holzhausen Gonçalves da Motta
Emiliana Holzhausen Gonçalves da Motta
ADArtur Figueiredo Delgado
Artur Figueiredo Delgado

1 August 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
IRIsadora Souza Rodriguez
Isadora Souza Rodriguez
PSPollyana Coelho Pessoa Santos
Pollyana Coelho Pessoa Santos
ADArtur Figueiredo Delgado
Artur Figueiredo Delgado
WCWerther Brunow de Carvalho
Werther Brunow de Carvalho

1 April 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
JFJuliana Ferreira Ferranti
Juliana Ferreira Ferranti
IRIsadora Souza Rodriguez
Isadora Souza Rodriguez
EMEmiliana Motta
Emiliana Motta
CJCíntia Johnston
Cíntia Johnston
WCWerther Brunow de Carvalho
Werther Brunow de Carvalho
ADArtur Figueiredo Delgado
Artur Figueiredo Delgado
SUMMARY Severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2 infection) is a new challenge for all countries, and children are predisposed to acquire this disease. Some studies have demonstrated more severe diseases in adults, but critically ill pediatric patients have been described in all ages. Pulmonary involvement is the major feature, and ventilatory support is common in critical cases. Nevertheless, other very important therapeutic approaches must be considered. In this article, we reviewed extensively all recent medical literature to point out the main clinical attitudes to support these pediatric patients during their period in respiratory support. Radiologic findings, fluid therapy, hemodynamic support, use of inotropic/vasopressors, nutritional therapy, antiviral therapy, corticosteroids, antithrombotic therapy, and immunoglobulins are analyzed to guide all professionals during hospitalization. We emphasize the importance of a multi-professional approach for adequate recovery.